Premature infant lung development

Premature infant lung development addresses the challenges faced by infants born before full gestational maturity, whose lungs are structurally and functionally underdeveloped. Immature alveolarization, surfactant deficiency, and weak respiratory muscles increase vulnerability to respiratory distress, chronic lung disease, and infections. Clinical manifestations include tachypnea, retractions, hypoxemia, and recurrent apnea, which can compromise oxygen delivery and growth. Assessment relies on continuous monitoring of oxygen saturation, imaging, and laboratory evaluation to guide interventions and anticipate complications.

Management strategies focus on supporting lung maturation and preventing long-term respiratory morbidity. Surfactant therapy, non-invasive ventilation, and careful oxygen titration form the cornerstone of acute care. Nutritional support, infection prevention, and careful fluid management further enhance outcomes. Long-term follow-up may include monitoring for bronchopulmonary dysplasia, airway reactivity, and exercise tolerance. Collaboration among neonatologists, pulmonologists, respiratory therapists, and caregivers ensures individualized care. Education on early recognition of respiratory compromise, adherence to therapy, and home care strategies is essential. Advances in neonatal intensive care, gentle ventilation techniques, and targeted therapies continue to improve survival and quality of life for premature infants with underdeveloped lungs.